Cocrystal Pharma, Inc. Annual Return On Equity in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Cocrystal Pharma, Inc. quarterly/annual Return On Equity history and growth rate from 2012 to 2023.
  • Cocrystal Pharma, Inc. Return On Equity for the quarter ending June 30, 2024 was -73.9 %, a 50% decline year-over-year.
  • Cocrystal Pharma, Inc. annual Return On Equity for 2023 was -56.9 %, a 22.2% increase from 2022.
  • Cocrystal Pharma, Inc. annual Return On Equity for 2022 was -73.1 %, a 281% decline from 2021.
  • Cocrystal Pharma, Inc. annual Return On Equity for 2021 was -19.2 %, a 10.3% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -56.9 +16.2 +22.2% Jan 1, 2023 Dec 31, 2023
2022 -73.1 -53.9 -281% Jan 1, 2022 Dec 31, 2022
2021 -19.2 +2.21 +10.3% Jan 1, 2021 Dec 31, 2021
2020 -21.4 +58 +73% Jan 1, 2020 Dec 31, 2020
2019 -79.4 -29.7 -59.7% Jan 1, 2019 Dec 31, 2019
2018 -49.7 -49.1 -8162% Jan 1, 2018 Dec 31, 2018
2017 -0.6 +48.8 +98.8% Jan 1, 2017 Dec 31, 2017
2016 -49.4 -22.7 -84.7% Jan 1, 2016 Dec 31, 2016
2015 -26.8 -24 -887% Jan 1, 2015 Dec 31, 2015
2014 -2.71 -55.2 -105% Jan 1, 2014 Dec 31, 2014
2013 52.5 -163 -75.7% Jan 1, 2013 Dec 31, 2013
2012 216 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.